“US supreme court to decide if companies can patent human genes”

US law gene patent Photograph: Mauricio Lima/AFP/Getty Images
US law gene patent
Photograph: Mauricio Lima/AFP/Getty Images

Author Karen McVeigh states arguments for and against patenting human genes.  Are human genes “products of nature”, not to be exploited for commercial interests?

Two gene patents held by biotech company Myriad Genetics are being challenged because, “The patents have stymied research and the free exchange of ideas,” according to the plaintiffs in this case.

Nearly 20% of the human genome – more than 4,000 genes, including some linked to Alzheimer’s disease and colon cancer – is already covered by at least one patent,” according to the report.

Myriad president Mark Capone argues that, “Adequate intellectual property protection,” must be maintained or else, “Companies would face significant obstacles conducting pioneering research.”

Christopher Mason, assistant professor at Weill Medical College, “Described the patenting of genes as ‘preposterous‘,” McVeigh reports.

Read the full story, click here.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s